Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myelomaSara Yousef, Djordje Atanackovic|Journal of Translational Medicine|2015Cited by 6
Engineering anti-CD229 CAR T cell selectivity for multiple myelomaJillian G. Baker, Erica R. Vander Mause, Michael Olson et al.|The Journal of Immunology|2022Cited by 0